大麻素 (CBD) 的潜力可以克服抗药性广泛的Acinetobacter baumannii
Atchariya Yosboonruang1,2, Anong Kiddee1,2, Achiraya Siriphap1,2
1Division of Microbiology and Parasitology, School of Medical Sciences, University of Phayao, Phayao, 56000, Thailand.
大麻素 (CBD) 显示出对抗广泛耐药的Acinetobacter baumannii的抗菌活性. CBD与抗生素协同作用,抑制生物膜和破坏细菌膜,提供了一种新的治疗策略.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 广泛耐药 (XDR) Acinetobacter baumannii由于多药性耐药性而构成了重大的临床挑战.
- 大麻素 (CBD) 是来自Cannabis sativa L.的非精神活性化合物,具有潜在的抗菌特性.
研究的目的:
- 评估CBD对XDR A. baumannii的抗菌和抗生物膜作用.
- 探索CBD的作用机制及其作为辅助疗法的潜力.
主要方法:
- 使用MALDI-TOF/MS.识别A. baumannii的分离物.
- 抗微生物敏感性测试 (磁盘扩散,汁微稀释),象棋板测试协同作用,生物膜测试 (水晶紫色,MTT),时间杀伤研究,膜完整性测试和扫描电子显微镜 (SEM).
主要成果:
- CBD显示对XDR A. baumannii分离物的活性.
- CBD与珍塔米辛,美罗和胆固醇协同作用,显著降低了它们所需的度.
- 组合疗法有效地抑制和消除了生物膜,而CBD诱导了快速杀死细菌和损伤膜.
结论:
- 作为常规抗生素的辅助疗法,CBD在治疗XDR A. baumannii感染方面表现有前途.
- CBD提高抗生素疗效和破坏细菌膜的能力为打击抗菌素耐药性提供了一种新的方法.
更多相关视频
07:41Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
相关概念视频
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Effectiveness
